Accesswire
16 Mar 2026, 13:00 UTC · 27w ago
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Verdict
Headline takes no side. We score JAGX +0.60 — strongly bullish.
- Expected · JAGX
+0.60strongly bullish
−1 bearish0bullish +1More positive than 74% of ticker scores this week



